Unichem Pharmaceuticals (USA), Inc., recalled one lot of Hydrochlorothiazide Tablets 25 mg 1000-count bottle to the consumer level. This generic drug is also called Hydrodiuril, Esidrix, or Microzide. This recall has been initiated as a precautionary measure due to the identification of a Clopidogrel (Plavix) tablet found in a bottle of the product.
The risk associated with mistakenly taking a Clopidogrel tablet instead of a Hydrochlorothiazide tablet is the increased probability of experiencing Clopidogrel's side effects which include bleeding and/or bruising. Patients with active bleeding or who are allergic to Clopidogrel or any component of the formulation may experience more serious adverse health consequences as a result of unknowingly consuming Clopidogrel. Additionally, missing a dose of Hydrochlorothiazide could result in uncontrolled blood pressure or swelling caused by excess fluid (edema). As per Unichem's internal investigation, this episode is an isolated event noted at one pharmacy and confined to the recalled lot.
Hydrochlorothiazide tablets are indicated for the management of high blood pressure and edema and are packaged in 1000-count bottles. The affected Hydrochlorothiazide tablets include Lot # GHYL15028 - Expiration April, 2018. This lot was distributed nationwide directly to wholesalers, retailers, and pharmacies from May 21 - 28, 2015.
See the Recall
See also Medical Law Perspectives, May 2013 Report: Drugs, Dosage, and Damage: Physician Liability for Prescribing or Administering Medication